An ophthalmology resident shares insights from experiences across Mexico, Europe, and the US.

A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

Could a single border zone imaging measurement predict how quickly a geographic atrophy (GA) lesion will grow? A border zone ...

BVI's Experience Hub in Sant Cugat, Spain, is designed to bring surgeon feedback directly into product design, with training needs tailored to different career stages. The facility replicates a ...

Warm compresses are frequently recommended indiscriminately, often without consideration of disease phenotype, inflammatory status or realistic thermal limitations. This article examines the ...

Artificial corneal endothelial implantation produced significant reductions in corneal thickness and improvements in visual acuity in patients with chronic corneal oedema, includi ...

What drives non-infectious uveitis in children, and how well do current treatments hold up over time? In a Saudi Arabian cohort, juvenile idiopathic arthritis (JIA) emerged as the leading cause, and ...

For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...

Chemical injuries to the ocular surface can be challenging to manage because they lie at the intersection of urgency and long-term consequences. The severity of these injuries depends on the type of ...

Immune checkpoint inhibitors (ICIs) have transformed oncology, enabling patients with previously untreatable malignancies to achieve durable responses. However, as the use of agents such as ...

In this single-centre case–control study, Astolfi et al, of the Alma Mater Studiorum University of Bologna and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy, collected conjunctival swabs ...

Khanani, MD, MA, FASRS, founded Clinical Trials at the Summit (CTS) 6 years ago, the vision was to bring all stakeholders in retinal drug development together under one roof. At this year's meeting, ...